Sale of fake obesity drugs driven by high prices, weight-loss desire prompts health concern

Ozempic and Mounjaro are brand names of the ‘GLP-1 receptor agonist’ class of medicines, which help one manage diabetes and obesity by targeting appetite and enhancing satiety, resulting in a…

Obesity treatment drugs to be new growth engine for pharma industry: Sun Pharma

New Delhi: Improving access to new age medicines for obesity and diabetes over the next few years would be a key enabler for the growth of the domestic pharmaceutical industry,…

Lilly launches Mounjaro KwikPen in India

Mumbai, August 14, 2025 — Eli Lilly and Company (India) has rolled out the Mounjaro (tirzepatide) KwikPen across the country, expanding treatment choices for people with type-2 diabetes and those…

Popular diabetes drug, Mounjaro, launched in India

Mounjaro (tirzepatide): A breakthrough drug for the treatment of Type 2 diabetes and obesity, has been released in India. The drug has been approved by the Central Drugs Standard Control Organization…